American Pacific Borate enhances DFS to deliver low capex starter project
American Pacific Borate (ASX:ABR) has enhanced its Fort Cady Borate Project DFS released on 17 December 2018 to include a low capex starter project.
The starter project is likely to change the game for ABR and was achieved by splitting Phase One into Phase One A and Phase One B, with Phase One A targeting the production of 40k stpa of SOP (potassium sulphate or K2SO4) and 6k stpa of boric acid (H3BO3).
Phase One B will increase boric acid production to 90k stpa.
The benefits of doing this are many and varied, however importantly the project substantially reduces pre-production capex from US$138 million to only US$36.8 million. That is an initial capital reduction of over $100 million.
Furthermore, pre-production capex has been reduced by around 75% whilst total capex has only increased by around 7%.
Overall, the project delivers exceptional financial metrics and is financeable on a standalone basis.
Also important to note is that this enhancement is likely to mean lower share dilution whilst preserving the targeted larger project and valuation.
“We are delighted with the enhancements of the DFS to include a low capex starter project that works on a standalone basis,” said ABR CEO Michael Schlumpberger.
“We now have pre-production capex of only US$36.8 million and a pathway to Phase Three that has an annual EBITDA in the first full year of production of over US$340 million.
“We have made the Fort Cady Project easier to finance, whilst limiting likely share dilution and preserving a massive EBITDA target in full production.
“Our ability to include such a low capex starter project emphasizes how unique the Fort Cady project is in the world of mining.”
The following table highlights the positive financial metrics for the Fort Cady Project.
The Phase One A financial metrics means ABR can target financing this project in isolation, whilst creating a sensible pathway to full production and an EBITDA target in the first full year of production of US$345 million.
The table below summarises the production targets by each construction Phase. The targets have not changed from the initial DFS.
The numbers couldn’t come at a better time for ABR, with Grand View Research estimating the global lithium-ion battery market is projected to reach US$93.1 billion by 2025 while growing at a CAGR of 17% during the forecasted period.
Furthermore, borate producers should continue to benefit from increasing demand for glass and ceramics across Asian countries where there is an absence of boron resources.
Given the location of the project near America's lithium hub in Nevada, which includes Tesla's Gigafactory, it could be an interesting 2019 for ABR.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.